{"id":"W2313479654","doi":"10.1093/annonc/mdw139","title":"Quality of life with palbociclib plus fulvestrant in previously treated hormone receptor-positive, HER2-negative metastatic breast cancer: patient-reported outcomes from the PALOMA-3 trial","year":2016,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":178,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sunnybrook Health Science Centre","funders":"Pfizer","keywords":"Fulvestrant; Palbociclib; Medicine; Placebo; Internal medicine; Quality of life (healthcare); Breast cancer; Metastatic breast cancer; Oncology; Cancer; Confidence interval; Anastrozole; Gynecology; Estrogen receptor; Tamoxifen","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005438331,0.0003088017,0.001633305,0.00009506706,0.00003920202,0.000003793346,0.000172534,0.0001282318,0.0002263098],"category_scores_gemma":[0.0005261194,0.0001541071,0.0001949736,0.0003404096,0.0007033798,0.000146117,0.00004213138,0.0001968355,0.000002968855],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000195173,"about_ca_system_score_gemma":0.0009843336,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01134751,"about_ca_topic_score_gemma":0.002561502,"domain_scores_codex":[0.9966678,0.0007783722,0.001290485,0.0004207595,0.000433803,0.0004087759],"domain_scores_gemma":[0.9953089,0.002084833,0.00139862,0.0004727977,0.0005680029,0.0001668958],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.4161136,0.002052668,0.2629928,0.00007141413,0.004197678,0.00008746792,0.006823941,0.00002689679,0.01528627,0.00007891057,0.0003376536,0.2919307],"study_design_scores_gemma":[0.1053178,0.00754232,0.8771815,0.000412241,0.0002500655,0.00002196959,0.001464498,0.000002365508,0.006820292,0.0003891143,0.0003597108,0.0002382021],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9819459,0.001010183,0.00009091135,0.01418386,0.00009787821,0.001678897,0.0008087656,0.00003044201,0.0001531797],"genre_scores_gemma":[0.9971638,0.0007366595,0.0006337848,0.001024795,0.00007119131,0.0002516036,0.00003343875,0.00003473054,0.00005000457],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6141886,"threshold_uncertainty_score":0.995236,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08696416881545778,"score_gpt":0.3862310724140349,"score_spread":0.2992669035985772,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}